NRAS and melanoma: Briefly, 58/124 (46.8%) primary melanomas and 70/150 (46.7%) metastatic tissues presented mutations in BRAF gene, whereas NRAS mutations were found in 19/124 (15.3%) primary tumors and 24/150 (16.0%) melanoma metastases (Table 3).